Teva Pharmaceutical Industries (TEVA) Financial Analysis & Valuation | Quarter Chart

Teva Pharmaceutical Industries (TEVA)

TEVA
Price: $34.07
Fair Value: 🔒
🔒score
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, ... more
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, a... more
Description Shares
Market Cap$39.67BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryILCEORichard D. Francis
IPO Date1982-02-16CAGR0.14%
Employees37,000Websitewww.tevapharm.com
Div. Yield—Payout Ratio—
Buy Back Yield—Total Yield—
TEVA chart loading...
Fundamentals Technicals
Enterprise Value$47.98BP/E Ratio25.43
Forward P/E10.98PEG Ratio0.35
P/S Ratio2.32P/B Ratio4.83
P/CF Ratio16.46P/FCF Ratio21.37
EPS$1.34EPS Growth 1Y—
EPS Growth 3Y—EPS Growth 5Y—
Revenue Growth 1Y4.41%Gross Margin0.52%
Operating Margin0.19%Profit Margin0.09%
ROE0.21%ROA0.04%
ROCE0.13%Current Ratio1.01
Quick Ratio0.78Cash Ratio0.28
Debt/Equity2.05Interest Coverage3.97
Altman Z Score0.9Piotroski Score7

View Teva Pharmaceutical Industries financial charts →